Objective: To provide primary care clinicians with a better understanding of management
issues in generalized anxiety disorder (GAD) and guide clinical practice with …

Objective: Generalized anxiety disorder (GAD) is common, chronic, and debilitating.
Treatment with benzodiazepines and newer antidepressants is often inadequate. This article …

Clinical and epidemiological data suggest that generalized anxiety disorder (GAD) is a
chronic illness causing patients to suffer for many years leading to significant distress in …

In recent years generalised anxiety disorder (GAD) has become a much better defined
disorder, with specific criteria distinguishing it from the other anxiety disorders; however, it …

Generalized anxiety disorder (GAD) is highly prevalent in primary care patients and is a
source of major morbidity. The low rate of recognition and diagnosis of GAD is often the …

Recent years have seen a near-doubling of the number of studies examining the effects of
psychotherapies for generalized anxiety disorder (GAD) in adults. The present article …

Background: Generalized anxiety disorder (GAD) is one of the most common psychiatric
disorders in primary care, although it is often underrecognized and undertreated. GAD is …

Generalized anxiety disorder (GAD) is characterized by chronic worry that may persist for
many years. It is a debilitating disorder, and effective long-term treatment is required …

Background Generalized anxiety disorder (GAD) is a common and serious disease with a
lifetime prevalence of 4.3% to 5.9%. It is underdiagnosed in primary care. Methods …

The purpose of this meta-analysis was to provide updated pooled effect sizes of evidence-
based psychotherapies and medications for generalized anxiety disorder (GAD) and to …